RYR1 potentially pathogenic sequence variations were identified in 56.9% of Japanese malignant hyperthermia-susceptible patients, differing markedly from North American and European populations.
Observational (n=58)
What is the frequency and distribution of RYR1 mutations in the Japanese malignant hyperthermia-susceptible population?
Comprehensive screening of the entire RYR1 gene is necessary in Japanese MH-susceptible individuals due to a distinct mutation distribution compared to Western populations and many mutations located outside typical hot spots.
BACKGROUND: Malignant hyperthermia (MH) is a disorder of calcium homeostasis in skeletal muscle triggered by volatile anesthetics or succinylcholine in susceptible persons. More than 100 mutations in the ryanodine receptor type 1 gene (RYR1) have been associated with MH susceptibility, central core disease, or both. RYR1 mutations may account for up to 70% of MH-susceptible cases. The authors aimed to determine the frequency and distribution of RYR1 mutations in the Japanese MH-susceptible population. METHODS: The authors selected 58 unrelated Japanese diagnosed as MH-susceptible for having an enhanced Ca-induced Ca release rate from the sarcoplasmic reticulum on chemically skinned muscle fibers. They sequenced the entire RYR1 coding region from genomic DNA. Muscle pathology was also characterized. RESULTS: Seven previously reported and 26 unknown RYR1 potentially pathogenic sequence variations were identified in 33 patients (56.9%). Of these patients, 48% had cores on muscle biopsy. The mutation detection rate was higher in patients with clear enhancement of Ca-induced Ca release rate (72.4%), whereas all patients with central core disease had RYR1 mutations. Six patients harbored potentially causative compound heterozygous sequence variations. CONCLUSIONS: Distribution and frequency of RYR1 mutations differed markedly from those of the North American and European MH-susceptible population. Comprehensive screening of the RYR1 gene is recommended for molecular investigations in MH-susceptible individuals, because many mutations are located outside the "hot spots." Based on the observed occurrence of compound heterozygous state, the prevalence of a possibly predisposing phenotype in the Japanese population might be as high as 1 in 2,000 people.
Ibarra et al. (Thu,) conducted a observational in Malignant hyperthermia susceptibility (n=58). RYR1 mutations was evaluated on Frequency and distribution of RYR1 mutations. RYR1 potentially pathogenic sequence variations were identified in 56.9% of Japanese malignant hyperthermia-susceptible patients, differing markedly from North American and European populations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: